tetano
Editor, Senior Moderator
Front Immunol
. 2024 Oct 10:15:1468456.
doi: 10.3389/fimmu.2024.1468456. eCollection 2024. The molecular mechanisms of CD8[SUP]+[/SUP] T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions
Shasha Deng[SUP] #[/SUP][SUP] 1 2 [/SUP], Zhihao Xu[SUP] #[/SUP][SUP] 1 3 [/SUP], Jing Hu[SUP] 4 [/SUP], Yunru Yang[SUP] 4 [/SUP], Fang Zhu[SUP] 4 [/SUP], Zhuan Liu[SUP] 4 [/SUP], Hongliang Zhang[SUP] 1 [/SUP], Songquan Wu[SUP] 1 [/SUP], Tengchuan Jin[SUP] 1 2 4 5 6 7 [/SUP]
Affiliations
Cytotoxic CD8[SUP]+[/SUP] T lymphocytes (CTLs) have been implicated in the severity of COVID-19. The TCR-pMHC ternary complex, formed by the T cell receptor (TCR) and peptide-MHC (major histocompatibility complex), constitutes the molecular basis of CTL responses against SARS-CoV-2. While numerous studies have been conducted on T cell immunity, the molecular mechanisms underlying CTL-mediated immunity against SARS-CoV-2 infection have not been well elaborated. In this review, we described the association between HLA variants and different immune responses to SARS-CoV-2 infection, which may lead to varying COVID-19 outcomes. We also summarized the specific TCR repertoires triggered by certain SARS-CoV-2 CTL epitopes, which might explain the variations in disease outcomes among different patients. Importantly, we have highlighted the primary strategies used by SARS-CoV-2 variants to evade T-cell killing: disrupting peptide-MHC binding, TCR recognition, and antigen processing. This review provides valuable insights into the molecule mechanism of CTL responses during SARS-CoV-2 infection, aiding efforts to control the pandemic and prepare for future challenges.
Keywords: HLA; SARS-CoV-2; TCR repertoire; TCR-pHLA; TCR-pMHC; cytotoxic T lymphocytes (CTL); epitope; mutations.
. 2024 Oct 10:15:1468456.
doi: 10.3389/fimmu.2024.1468456. eCollection 2024. The molecular mechanisms of CD8[SUP]+[/SUP] T cell responses to SARS-CoV-2 infection mediated by TCR-pMHC interactions
Shasha Deng[SUP] #[/SUP][SUP] 1 2 [/SUP], Zhihao Xu[SUP] #[/SUP][SUP] 1 3 [/SUP], Jing Hu[SUP] 4 [/SUP], Yunru Yang[SUP] 4 [/SUP], Fang Zhu[SUP] 4 [/SUP], Zhuan Liu[SUP] 4 [/SUP], Hongliang Zhang[SUP] 1 [/SUP], Songquan Wu[SUP] 1 [/SUP], Tengchuan Jin[SUP] 1 2 4 5 6 7 [/SUP]
Affiliations
- PMID: 39450171
- PMCID: PMC11499136
- DOI: 10.3389/fimmu.2024.1468456
Cytotoxic CD8[SUP]+[/SUP] T lymphocytes (CTLs) have been implicated in the severity of COVID-19. The TCR-pMHC ternary complex, formed by the T cell receptor (TCR) and peptide-MHC (major histocompatibility complex), constitutes the molecular basis of CTL responses against SARS-CoV-2. While numerous studies have been conducted on T cell immunity, the molecular mechanisms underlying CTL-mediated immunity against SARS-CoV-2 infection have not been well elaborated. In this review, we described the association between HLA variants and different immune responses to SARS-CoV-2 infection, which may lead to varying COVID-19 outcomes. We also summarized the specific TCR repertoires triggered by certain SARS-CoV-2 CTL epitopes, which might explain the variations in disease outcomes among different patients. Importantly, we have highlighted the primary strategies used by SARS-CoV-2 variants to evade T-cell killing: disrupting peptide-MHC binding, TCR recognition, and antigen processing. This review provides valuable insights into the molecule mechanism of CTL responses during SARS-CoV-2 infection, aiding efforts to control the pandemic and prepare for future challenges.
Keywords: HLA; SARS-CoV-2; TCR repertoire; TCR-pHLA; TCR-pMHC; cytotoxic T lymphocytes (CTL); epitope; mutations.